Dhargam Aljebouri: First Molecularly Characterized Para-Bombay Phenotype in the Arab World
Dhargam Aljebouri, Laboratory Director at Clinical Immunology, Allergy and Transfusion Medicine – Specialized Immunosciences Laboratory, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Transfusion, adding:
“Proud to share that our case report (First molecularly characterized Para-Bombay phenotype in Iraq: Clinical, serological and genetic insights with implications for transfusion safety), has now been published in Transfusion (The Journal of AABB).
This represents the first molecularly characterized Para-Bombay phenotype reported from Iraq and, to the best of my knowledge, the first published molecularly characterized Para-Bombay case from the Arab world.
This work highlights the value of integrating advanced immunohematology, secretor studies and molecular characterization of FUT1/FUT2 to improve recognition of H-deficient phenotypes and transfusion safety.
My sincere thanks to all co-authors for their valuable contributions and collaboration throughout this work, with special appreciation to the team of the Specialized Immunosciences Laboratory, Al-Moayed Medical Network for their dedicated technical support and laboratory efforts.
I dedicate this publication to the memory of my beloved sister, Zahraa.
A meaningful contribution to rare blood group science and transfusion medicine from Iraq.”
Title: First molecularly characterized Para-Bombay phenotype in Iraq: Clinical, serological and genetic insights with implications for transfusion safety
Authors: Dhargam Muhamed Aljebouri, Mohammed Aljadiri, Bassam Alshaikhli, Rawa Alattabi, Arwa Alkhamess, Sajjad Aldoori, Yousif Suleiman
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 25, 2026, 02:18Dai H. Chung: Delivering Lyfgenia to Pediatric Patients With Sickle Cell Disease
-
Oct 25, 2026, 02:17Marilyn Baffoe-Bonnie: What Does It Mean to Be Cured of Sickle Cell Disease?
-
Oct 25, 2026, 02:15Tamara Stipcevic: A Hand-Powered Device for Rapid Blood Typing and Hematocrit Estimation
-
Oct 25, 2026, 02:14Rhonda Patrick: Microplastics Generate Damaging Free Radicals Simply by Contacting Water
-
Oct 25, 2026, 02:12Chokri Ben Lamine: Rilzabrutinib – Oral BTK Inhibitor for ITP
-
Oct 25, 2026, 02:12Michael H. Tomasson: Self-Experimentation That Revealed the Immune Mechanism of ITP
-
Oct 25, 2026, 02:10Nabiha Huq Saifee: Do You Help Make Platelet Transfusion Decisions Before Lumbar Puncture?
-
Oct 25, 2026, 02:09Sebastian Szmit: Congratulations to Isabelle Mahé on Her New Cardio-Oncology Paper
-
Oct 24, 2026, 16:57Pall T. Onundarson: Fiix Prothrombin Time Advancing Precision in Anticoagulation Management